Analysis of Sasang Constitutional Medicine as an Optimal Preventive Care Strategy for Hemophilia Patients

Copyright © 2020 Mi Kyung Lee et al..

Introduction. Medical improvements have allowed hemophilia patients to anticipate an increased quality of life and life expectancy similar to that of the general population. Analysis of the potential disease symptoms of hemophilia patients based on a survey of Sasang Constitutional Medicine (SCM) is important for optimal preventive care and adjunctive therapy to avoid life-threating complications.

AIM: To predict potential disease symptoms from the viewpoint of SCM as a preventive care strategy for hemophilia patients.

METHODS: Sixty-one hemophilia patients responded to a survey on Sasang constitutional classification, hemophilia disease pattern, and original symptoms.

RESULTS: In terms of SCM type, the 61 of hemophilia patients included 37 Tae-Eum (60.7%), 18 So-Yang (29.5%), and 6 So-Eum (12.5%). Hemophilia was found to be higher in Tae-Eum type and lower in So-Yang and So-Eum types, while considering the distributional rate of Korean Sasang types. Most of the patients with Tae-Eum type had Joyeol or Ganyeol. Furthermore, the incidences of diabetes and high blood pressure were greater in Tae-Eum type than in those of other types.

CONCLUSION: In order to increase the quality of life and overall life expectancy, hemophilia patients with Tae-Eum type should be treated through management according to SCM along with medicine against hemophilia as long-term preventive care. Diabetes and high blood pressure should be regularly monitored in patients with Tae-Eum type.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:2020

Enthalten in:

BioMed research international - 2020(2020) vom: 12., Seite 4147803

Sprache:

Englisch

Beteiligte Personen:

Lee, Mi Kyung [VerfasserIn]
Hwang, Minwoo [VerfasserIn]
Oh, Hyunjoo [VerfasserIn]
Kim, Kyoung Soo [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Completed 24.11.2020

Date Revised 13.04.2022

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1155/2020/4147803

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM306829355